To assess the efficacy of hair removing cream on healthy human subjects.

To evaluate the efficacy of hair removing cream formulations for hair.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/12/010907

Enrollment

Registered

2017-12-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Hair Removal cream: The Hair removal cream contains Aqua, Cetostearyl Alcohol,Thioglycollic acid, Paraffinum Liquidum,Urea, Calcium Hydroxide,Cetereath-20,Talc,Sodium hydroxide,Perfume

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects in generally good health 2.Subjects in the age group of 18-35 years. 3.Subjects with moderate hair growth on lower outer forearms. 4.Subjects without any cuts, marks and open wounds on lower outer forearms. 5.Subject has not participated in a similar investigation in the past four weeks. 6.Subjects have not used a similar product for the last four weeks. 7.Subjects willing to give a written informed consent and come for regular follow up.

Exclusion criteria

Exclusion criteria: 1.Subjects with known allergies or sensitivities to cosmetic products, toiletries or its components like fragrances, preservatives,hydroquinone, vitamin C, Niacin amide,retinol, soy etc. 2.Currently or has been using topical retinoids, alpha-hydroxy and/or beta-hydroxy acids,hydroquinone or any whitening/Fairness preparation in any form (cleanser, toner, cream or soaps) within the last 1 month. 3.Currently or has been undergoing dermatologist skin treatments or procedures within the last 1 month. 4.Currently or has been involved in another skin care clinical investigation within the last 3 months. 5.Subjects who have pre-existing or dormant dermatologic conditions (e.g., psoriasis, rosacea, rashes, eczema, many and/or severe excoriations etc.) that could interfere with the outcome of the study as determined by the investigator. 6.Subjects with scars which could interfere with expert grader and/or instrumental evaluations. 7.Subjects who are nursing as determined by the investigator interview during screening or pregnant as determined by the Urine pregnancy testing after screening. 8.Subjects viewed by the investigator as not being able to complete the study.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of hair removing cream and skin darkening effect on Repetitive usage on healthy human subjectsTimepoint: Day 1, Day 30 and Day 60	—

Secondary

Measure	Time frame
safety of the subject throughout the studyTimepoint: Day 1, Day 30 and Day 60	—

Countries

India

Contacts

Public ContactManmohan Sharma

Dabur India Ltd.

manmohan.sharma@dabur.com01203378591

Outcome results